MyMedR

Displaying all 3 publications

Abstract:

Sort:

First record of the genus Aetius O. Pickard-Cambridge, 1897 from China, with description of a new species (Araneae, Corinnidae, Castianeirinae)

Zhang L, Mu Y, Zhang F

Biodivers Data J, 2022;10:e96594.
PMID: 36761594 DOI: 10.3897/BDJ.10.e96594

BACKGROUND: The genus Aetius O. Pickard-Cambridge, 1897 has been discovered in Sri lanka, India, Malaysia (Borneo), Thailand and Ivory Coast and comprises four species: A.bicuspidatus Yamasaki, 2020, A.decollatus O. Pickard-Cambridge, 1897, A.nocturnus Deeleman-Reinhold, 2001 and A.tuberculatus (Haddad, 2013).
NEW INFORMATION: The genus Aetius O. Pickard-Cambridge, 1897 is reported for the first time in China (Yunnan Province) and includes three species: one new species and two newly-recorded species. One new species is described, based on both sexes: A.maculatus sp. n. Additionally, A.bicuspidatus Yamasaki, 2020 and A.nocturnus Deeleman-Reinhold, 2001, are newly recorded from China, with photographs of habitus and genitalia being provided.
Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer

Mu Y, Tong J, Wang Y, Yang Y, Wu X

Front Immunol, 2023;14:1213161.
PMID: 37457710 DOI: 10.3389/fimmu.2023.1213161

Adoptive transfer of natural killer (NK) cells represents a viable treatment method for patients with advanced malignancies. Our team previously developed a simple, safe, and cost-effective method for obtaining high yields of pure and functional NK cells from cord blood (CB) without the need for cell sorting, feeder cells, or multiple cytokines. We present the case of a 52-year-old female patient diagnosed with poorly differentiated stage IVB (T3N2M1) endometrial cancer, who exhibited leukemoid reaction and pretreatment thrombocytosis as paraneoplastic syndromes. The patient received two courses of CB-derived NK (CB-NK) cell immunotherapy between March and September 2022, due to her extremely low NK cell activity. Two available CB units matched at 8/10 HLA with KIR-mismatch were chosen, and we were able to produce NK cells with high yield (>1.0×1010 NK cells), purity (>90%), and function (>80%) from CB without cell sorting, feeder cells, or multiple cytokines. These cells were then adoptively transferred to the patient. No adverse effects or graft-versus-host disease were observed after infusion of CB-NK cells. Our clinical experience supports the efficacy of CB-NK cell treatment in increasing NK cell activity, depleting tumor activity, improving quality of life, and reducing the size of abdominal and pelvic masses with the disappearance of multiple lymph node metastases through the regulation of systemic antitumor immunity. Remarkably, the white blood cell and platelet counts decreased to normal levels after CB-NK cell immunotherapy. This clinical work suggests that CB-NK cell immunotherapy holds promise as a therapeutic approach for endometrial cancer.
Enhanced Electrocatalytic Hydrogen Peroxide Production via a CuWO4/WO3 Heterojunction with High Selectivity and Stability

Liu Y, Liu H, Qian J, Luan J, Mu Y, Xiao C, et al.

ACS Appl Mater Interfaces, 2025 Jan 22;17(3):5026-5037.
PMID: 39801065 DOI: 10.1021/acsami.4c19881

The electrocatalytic conversion of oxygen to hydrogen peroxide offers a promising pathway for sustainable energy production. However, the development of catalysts that are highly active, stable, and cost-effective for hydrogen peroxide synthesis remains a significant challenge. In this study, a novel polyacid-based metal-organic coordination compound (Cu-PW) was synthesized using a hydrothermal approach. Cu-PW served as a precursor to construct a composite electrocatalyst featuring a heterointerface between CuWO4 and WO3 (CuWO4/WO3) through pyrolysis. The CuWO4/WO3 heterojunction exhibits an impressive H2O2 selectivity of 91.84% at 0.5 V, marking a 19.65% improvement compared to the pristine Cu-PW. Furthermore, the CuWO4/WO3 catalyst demonstrates exceptional stability, maintaining continuous operation for 29 h. At 0.1 V, it delivers a hydrogen peroxide yield of 1537.8 mmol g-1 h-1, with a Faraday efficiency (FE) of 85%. Additionally, this catalyst effectively degrades methyl blue, achieving a 95% removal from an aqueous system within 30 min. Theoretical analysis further corroborates the high electroactivity of CuWO4/WO3 heterojunction structure. The Cu-O-W bridge formed during the reaction facilitates interfacial electron transport and enhances the role of the W-O bond in proton adsorption and transfer kinetics. This strong interfacial coupling in CuWO4/WO3 promotes electron transfer and the formation of *OOH intermediates, thereby favoring hydrogen peroxide generation. Hence, the as-prepared CuWO4/WO3 demonstrates great potential as an efficient electrocatalyst for the green synthesis of hydrogen peroxide, exhibiting high efficiency as a two-electron oxygen reduction reaction catalyst. This work offers a new approach for fabricating CuWO4/WO3 electrocatalyst with high electroactivity and selectivity, paving the way for cost-effective and sustainable hydrogen peroxide production, significantly reducing reliance on the conventional anthraquinone process.

Filters

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links